These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6597712)

  • 21. HLA-linked hemochromatosis and other forms of iron overload.
    Bloom PD; Gordeuk VR; MacPhail AP
    Dermatol Clin; 1995 Jan; 13(1):57-63. PubMed ID: 7712651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening of hereditary spherocytosis and pyruvate kinase deficiency by automated blood count using erythrocytic and reticulocytic parameters.
    Bobée V; Daliphard S; Schrapp A; Lahary A
    Int J Lab Hematol; 2018 Dec; 40(6):697-703. PubMed ID: 30184319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hereditary enzyme defects of erythrocytes: glucose-6-phosphate dehydrogenase deficiency and pyruvate kinase deficiency].
    Sedano II; Röthlisberger B; Huber AR
    Ther Umsch; 2006 Jan; 63(1):47-56. PubMed ID: 16450734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary spherocytosis and hemochromatosis.
    Brandenberg JB; Demarmels Biasiutti F; Lutz HU; Wuillemin WA
    Ann Hematol; 2002 Apr; 81(4):202-9. PubMed ID: 11976822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietin in the treatment of iron overload in a patient with hemolytic anemia and pyruvate kinase deficiency.
    Vukelja SJ
    Acta Haematol; 1994; 91(4):199-200. PubMed ID: 7976118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intestinal iron absorption under the influence of available storage iron and erythroblastic hyperplasia. Comparative studies in children with hereditary spherocytosis, nonspherocytic enzymopenic hemolytic anemia, acquired hemolytic anemia, vitamin B12 deficiency induced megaloblastic anemia, erythroblastic hypoplasia and aplastic anemia.
    Bender-Götze C; Heinrich HC; Gabbe EE; Oppitz KH; Schröter W; Whang DH; Schäfer KH
    Z Kinderheilkd; 1975; 118(4):283-301. PubMed ID: 1130121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-existence of hereditary spherocytosis and a new red cell pyruvate kinase variant: PK mallorca.
    Zarza R; Moscardó M; Alvarez R; García J; Morey M; Pujades A; Vives-Corrons JL
    Haematologica; 2000 Mar; 85(3):227-32. PubMed ID: 10702808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rare combination of two inherited disorders in one patient: pyruvate kinase deficiency and hemochromatosis.
    Arnold H; Blume KG
    Ann Hematol; 2009 Aug; 88(8):815-6. PubMed ID: 19137298
    [No Abstract]   [Full Text] [Related]  

  • 29. Iron status in red cell pyruvate kinase deficiency: study of Italian cases.
    Zanella A; Berzuini A; Colombo MB; Guffanti A; Lecchi L; Poli F; Cappellini MD; Barosi G
    Br J Haematol; 1993 Mar; 83(3):485-90. PubMed ID: 8485056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
    Barton JC; Wiener HW; Acton RT; Go RC
    Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The new iron age.
    Trinder D; Macey DJ; Olynyk JK
    Int J Mol Med; 2000 Dec; 6(6):607-12. PubMed ID: 11078817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How little we know about the absorption of iron.
    Beutler E
    Am J Clin Nutr; 1997 Aug; 66(2):419-20. PubMed ID: 9250123
    [No Abstract]   [Full Text] [Related]  

  • 33. iron-overload-associated myopathy in patients on maintenance haemodialysis: a histocompatibility-linked disorder.
    Bregman H; Gelfand MC; Winchester JF; Manz HJ; Knepshield JH; Schreiner GE
    Lancet; 1980 Oct; 2(8200):882-5. PubMed ID: 6107546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary hemochromatosis with hereditary spherocytosis.
    Zimelman AP; Miller A
    Arch Intern Med; 1980 Jul; 140(7):983-4. PubMed ID: 7387309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
    Press RD; Flora K; Gross C; Rabkin JM; Corless CL
    Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anion exchange protein (band 3) in human erythrocytes characterized by different abnormalities.
    Giuliani A; Marini S; Ferroni L; Condo SG; Ramacci MT; Giardina B
    Clin Chim Acta; 1993 Nov; 220(2):211-7. PubMed ID: 8111964
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical and biochemical expression of the genetic abnormality in idiopathic hemochromatosis.
    Valberg LS; Lloyd DA; Ghent CN; Flanagan PR; Sinclair NR; Stiller CR; Chamberlain MJ
    Gastroenterology; 1980 Nov; 79(5 Pt 1):884-92. PubMed ID: 7419013
    [No Abstract]   [Full Text] [Related]  

  • 38. [Serum iron in hemolytic anemia (author's transl)].
    Schubothe H; Blume KG; Busch D; Felgentreu C; Weber S
    Klin Wochenschr; 1975 Feb; 53(4):181-3. PubMed ID: 1123896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron overload.
    Iancu TC
    Mol Aspects Med; 1983; 6(1):1-100. PubMed ID: 6371428
    [No Abstract]   [Full Text] [Related]  

  • 40. HFE-associated hereditary hemochromatosis.
    Eijkelkamp EJ; Yapp TR; Powell LW
    Can J Gastroenterol; 2000 Feb; 14(2):121-5. PubMed ID: 10694284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.